Skip to content

Comparative study of pregnancy outcomes of clomiphene and growth hormone adjuvant therapy with clomiphene alone in poor ovarian responders with a standard IVF treatment with antagonist protocol

Comparative study of pregnancy outcomes of clomiphene and growth hormone adjuvant therapy with clomiphene alone in poor ovarian responders with a standard In vitro fertilization(IVF) treatment with antagonist protocol

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170315033085N8
Enrollment
81
Registered
2025-08-30
Start date
2025-07-14
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility

Interventions

Intervention 1: Intervention group 1: Patients (n=27) treated with clomiphene (2 tablets of 50 mg, daily for 5 days) from the third day of menstruation along with the start of gonadotropin until the t

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Individuals with poor response (age =40 years or antral follicle count (AFC ) <3 in each ovary or poor response in the previous cycle) and without any uncontrolled underlying cardiac, hepatic, or renal disease, as well as normal male factor, thyroid, and prolactin levels will be included in the study.

Exclusion criteria

Exclusion criteria: Ovarian failure and cycle cancellation.

Design outcomes

Primary

MeasureTime frame
Number of Metaphase II oocytes. Timepoint: Post-intervention (10-12) days after the start of the intervention and ovarian stimulation (at the time of oocyte retrieval ). Method of measurement: Number of oocyte (MII) after oocyte retrieval by embryologist.;Number of embryos formed and their grade. Timepoint: Number of embryo after oocyte retrieval by embryologist. Method of measurement: Number of embryos formed and their grade (according to the Gardner embryo grading system).

Secondary

MeasureTime frame
Chemical pregnancy rate. Timepoint: Two weeks after embryo transfer. Method of measurement: Pregnancy test.;Clinical pregnancy rate. Timepoint: five weeks after embryo transfer. Method of measurement: Sonography.;Implantation rate. Timepoint: five weeks after embryo transfer. Method of measurement: Sonography.;Early miscarriage and late miscarriage. Timepoint: Before12weeksand 12-20 weeks. Method of measurement: Bleeding and expulsion of the fetus.;Multiple pregnancy rate. Timepoint: five weeks after embryo transfer. Method of measurement: Sonography.;Ongoing pregnancy. Timepoint: 12 weeks. Method of measurement: Sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMalihe Afiat

Mashhad University of Medical Sciences

Afiatm@mums.ac.ir+98 51 3853 4021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026